Background/Objectives: The incidence of colorectal cancer in Hungary exceeds the EU (European Union) average, and the cancer mortality rate is also among the highest in the country. The COVID-19 pandemic has impacted various areas of healthcare, including cancer diagnosis and treatment. Due to the measures taken to combat the COVID-19 pandemic, not only newly suspected cancer patients but also those already diagnosed and undergoing treatment faced numerous difficulties. Methods: The study included 198 patients with colorectal cancer, of whom 43 participants were newly diagnosed cases. Due to low case numbers in certain COVID-19 waves, adjacent waves were merged for statistical analysis. The number of newly diagnosed colorectal cancer cases across COVID-19 waves was compared using one-way ANOVA, stage distribution differences and the proportion of missed treatments were assessed with Fisher's exact test. In follow-up patients, changes were analyzed using the Wilcoxon signed-rank test. Differences in tumor size categories were examined using chi-square tests.
Study Type
OBSERVATIONAL
Enrollment
198
Szent Margit Hospital
Budapest, Hungary
Tumor stage distribution across COVID-19 pandemic waves
Comparison of colorectal cancer tumor stage (AJCC 8th edition) across different COVID-19 pandemic waves and the post-COVID period based on MRI findings.
Time frame: September 2020 - December 2023
Number of newly diagnosed colorectal cancer cases
Monthly number of newly diagnosed colorectal cancer cases across COVID-19 waves and the post-COVID period.
Time frame: September 2020 - December 2023
TNM classification
TNM classification of colorectal cancer according to the AJCC 8th edition during different COVID-19 pandemic waves in newly diagnosed and follow-up patients.
Time frame: September 2020 - December 2023
Tumor progression or regression in follow-up patients
Change in tumor stage between previous imaging and most recent MRI examination.
Time frame: September 2020 - December 2023
Missed oncologic treatments
Occurrence of missed or delayed oncologic treatments documented during the COVID-19 pandemic period.
Time frame: September 2020 - December 2023
Presence and distribution of metastases
Presence, number, and organ distribution of metastatic disease based on imaging findings.
Time frame: September 2020 - December 2023
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.